{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:18:59Z","timestamp":1790536739754,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"18","license":[{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Project of Science and Technology of Hebei Province","award":["21377719D"],"award-info":[{"award-number":["21377719D"]}]},{"name":"Project of Science and Technology of Hebei Province","award":["21377719D"],"award-info":[{"award-number":["21377719D"]}]},{"name":"Project of Science and Technology of Hebei Province","award":["21377719D"],"award-info":[{"award-number":["21377719D"]}]},{"name":"Project of Science and Technology of Hebei Province","award":["21377719D"],"award-info":[{"award-number":["21377719D"]}]},{"name":"Project of Science and Technology of Hebei Province","award":["21377719D"],"award-info":[{"award-number":["21377719D"]}]},{"name":"Project of Science and Technology of Hebei Province","award":["21377719D"],"award-info":[{"award-number":["21377719D"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s00432-023-05412-8","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T09:02:58Z","timestamp":1695114178000},"page":"16717-16727","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Identification of ferroptosis-related proteins in ameloblastoma based on proteomics analysis"],"prefix":"10.1007","volume":"149","author":[{"given":"Haiyang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruisi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,19]]},"reference":[{"key":"5412_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.semcancer.2019.02.001","volume":"59","author":"V \u00c1lvarez-Garcia","year":"2019","unstructured":"\u00c1lvarez-Garcia V, Tawil Y, Wise HM, Leslie NR (2019) Mechanisms of PTEN loss in cancer: It\u2019s all about diversity. Semin Cancer Biol 59:66\u201379. https:\/\/doi.org\/10.1016\/j.semcancer.2019.02.001","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"5412_CR2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/chromsci\/bmw167","volume":"55","author":"B Aslam","year":"2017","unstructured":"Aslam B, Basit M, Nisar MA, Khurshid M, Rasool MH (2017) Proteomics: technologies and their applications. J Chromatogr Sci 55(2):182\u2013196. https:\/\/doi.org\/10.1093\/chromsci\/bmw167","journal-title":"J Chromatogr Sci"},{"key":"5412_CR3","doi-asserted-by":"publisher","unstructured":"Ayuk, S. M., & Abrahamse, H. (2019). mTOR signaling pathway in cancer targets photodynamic therapy In Vitro. Cells, 8(5). https:\/\/doi.org\/10.3390\/cells8050431","DOI":"10.3390\/cells8050431"},{"issue":"3","key":"5412_CR4","doi-asserted-by":"publisher","first-page":"H659","DOI":"10.1152\/ajpheart.00452.2017","volume":"314","author":"Y Baba","year":"2018","unstructured":"Baba Y, Higa JK, Shimada BK, Horiuchi KM, Suhara T, Kobayashi M, Woo JD, Aoyagi H, Marh KS, Kitaoka H, Matsui T (2018) Protective effects of the mechanistic target of rapamycin against excess iron and ferroptosis in cardiomyocytes. Am J Physiol Heart Circ Physiol 314(3):H659-h668. https:\/\/doi.org\/10.1152\/ajpheart.00452.2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"5412_CR5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev-nutr-071714-034355","volume":"35","author":"A Caron","year":"2015","unstructured":"Caron A, Richard D, Laplante M (2015) The roles of mTOR complexes in lipid metabolism. Annu Rev Nutr 35:321\u2013348. https:\/\/doi.org\/10.1146\/annurev-nutr-071714-034355","journal-title":"Annu Rev Nutr"},{"issue":"3","key":"5412_CR6","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.oooo.2013.06.013","volume":"116","author":"R Chaisuparat","year":"2013","unstructured":"Chaisuparat R, Yodsanga S, Montaner S, Jham BC (2013) Activation of the Akt\/mTOR pathway in dentigerous cysts, odontogenic keratocysts, and ameloblastomas. Oral Surg Oral Med Oral Pathol Oral Radiol 116(3):336\u2013342. https:\/\/doi.org\/10.1016\/j.oooo.2013.06.013","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"5412_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.bbrc.2021.02.137","volume":"550","author":"M Chen","year":"2021","unstructured":"Chen M, Jiang Y, Sun Y (2021) KDM4A-mediated histone demethylation of SLC7A11 inhibits cell ferroptosis in osteosarcoma. Biochem Biophys Res Commun 550:77\u201383. https:\/\/doi.org\/10.1016\/j.bbrc.2021.02.137","journal-title":"Biochem Biophys Res Commun"},{"key":"5412_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/jop.13433","author":"Y Cui","year":"2023","unstructured":"Cui Y, Li H, Xiao T, Zhang X, Hou Y, Li H, Li X (2023) A proteomics study to explore differential proteins associated with the pathogenesis of ameloblastoma. J Oral Pathol Med. https:\/\/doi.org\/10.1111\/jop.13433","journal-title":"J Oral Pathol Med"},{"issue":"5","key":"5412_CR9","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, Morrison B 3rd, Stockwell BR (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149(5):1060\u20131072. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042","journal-title":"Cell"},{"key":"5412_CR10","doi-asserted-by":"publisher","unstructured":"Dodson M, Castro-Portuguez R, Zhang DD (2019) NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol, 23: 101107. https:\/\/doi.org\/10.1016\/j.redox.2019.101107","DOI":"10.1016\/j.redox.2019.101107"},{"issue":"6","key":"5412_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s12032-023-01993-z","volume":"40","author":"M Ebeling","year":"2023","unstructured":"Ebeling M, Scheurer M, Sakkas A, Pietzka S, Schramm A, Wilde F (2023) BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature. Med Oncol 40(6):163. https:\/\/doi.org\/10.1007\/s12032-023-01993-z","journal-title":"Med Oncol"},{"issue":"9","key":"5412_CR12","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/jop.13228","volume":"50","author":"YC Goh","year":"2021","unstructured":"Goh YC, Siriwardena B, Tilakaratne WM (2021) Association of clinicopathological factors and treatment modalities in the recurrence of ameloblastoma: Analysis of 624 cases. J Oral Pathol Med 50(9):927\u2013936. https:\/\/doi.org\/10.1111\/jop.13228","journal-title":"J Oral Pathol Med"},{"issue":"4","key":"5412_CR13","first-page":"886","volume":"59","author":"H Hosoi","year":"1999","unstructured":"Hosoi H, Dilling MB, Shikata T, Liu LN, Shu L, Ashmun RA, Germain GS, Abraham RT, Houghton PJ (1999) Rapamycin causes poorly reversible inhibition of mTOR and induces p53-independent apoptosis in human rhabdomyosarcoma cells. Cancer Res 59(4):886\u2013894","journal-title":"Cancer Res"},{"key":"5412_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/s0076-6879(08)03611-2","volume":"452","author":"T Ikenoue","year":"2009","unstructured":"Ikenoue T, Hong S, Inoki K (2009) Monitoring mammalian target of rapamycin (mTOR) activity. Methods Enzymol 452:165\u2013180. https:\/\/doi.org\/10.1016\/s0076-6879(08)03611-2","journal-title":"Methods Enzymol"},{"issue":"4","key":"5412_CR15","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nrurol.2018.9","volume":"15","author":"T Jamaspishvili","year":"2018","unstructured":"Jamaspishvili T, Berman DM, Ross AE, Scher HI, De Marzo AM, Squire JA, Lotan TL (2018) Clinical implications of PTEN loss in prostate cancer. Nat Rev Urol 15(4):222\u2013234. https:\/\/doi.org\/10.1038\/nrurol.2018.9","journal-title":"Nat Rev Urol"},{"issue":"5","key":"5412_CR16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrclinonc.2018.28","volume":"15","author":"F Janku","year":"2018","unstructured":"Janku F, Yap TA, Meric-Bernstam F (2018) Targeting the PI3K pathway in cancer: are we making headway? Nat Rev Clin Oncol 15(5):273\u2013291. https:\/\/doi.org\/10.1038\/nrclinonc.2018.28","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"5412_CR17","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M (2021) Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 22(4):266\u2013282. https:\/\/doi.org\/10.1038\/s41580-020-00324-8","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"5412_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1172\/jci73939","volume":"125","author":"YC Kim","year":"2015","unstructured":"Kim YC, Guan KL (2015) mTOR: a pharmacologic target for autophagy regulation. J Clin Invest 125(1):25\u201332. https:\/\/doi.org\/10.1172\/jci73939","journal-title":"J Clin Invest"},{"issue":"5","key":"5412_CR19","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.1601-0825.2006.01321.x","volume":"13","author":"H Kumamoto","year":"2007","unstructured":"Kumamoto H, Ooya K (2007) Immunohistochemical detection of phosphorylated Akt, PI3K, and PTEN in ameloblastic tumors. Oral Dis 13(5):461\u2013467. https:\/\/doi.org\/10.1111\/j.1601-0825.2006.01321.x","journal-title":"Oral Dis"},{"key":"5412_CR20","doi-asserted-by":"publisher","unstructured":"Lei G, Zhuang L, Gan B (2021) mTORC1 and ferroptosis: Regulatory mechanisms and therapeutic potential. Bioessays, 43(8): e2100093. https:\/\/doi.org\/10.1002\/bies.202100093","DOI":"10.1002\/bies.202100093"},{"issue":"7","key":"5412_CR21","first-page":"660","volume":"5","author":"N Li","year":"2012","unstructured":"Li N, Zhong M, Song M (2012) Expression of phosphorylated mTOR and its regulatory protein is related to biological behaviors of ameloblastoma. Int J Clin Exp Pathol 5(7):660\u2013667","journal-title":"Int J Clin Exp Pathol"},{"issue":"4","key":"5412_CR22","first-page":"5236","volume":"8","author":"N Li","year":"2015","unstructured":"Li N, Sui J, Liu H, Zhong M, Zhang M, Wang Y, Hao F (2015) Expression of phosphorylated Akt\/mTOR and clinical significance in human ameloblastoma. Int J Clin Exp Med 8(4):5236\u20135244","journal-title":"Int J Clin Exp Med"},{"issue":"2","key":"5412_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao N, Sun B, Wang G (2020) Ferroptosis: past, present and future. Cell Death Dis 11(2):88. https:\/\/doi.org\/10.1038\/s41419-020-2298-2","journal-title":"Cell Death Dis"},{"issue":"4","key":"5412_CR24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","volume":"21","author":"GY Liu","year":"2020","unstructured":"Liu GY, Sabatini DM (2020) mTOR at the nexus of nutrition, growth, ageing and disease. Nat Rev Mol Cell Biol 21(4):183\u2013203. https:\/\/doi.org\/10.1038\/s41580-019-0199-y","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5412_CR25","doi-asserted-by":"publisher","unstructured":"Mafi S, Mansoori B, Taeb S, Sadeghi H, Abbasi R, Cho WC, Rostamzadeh D (2021) mTOR-Mediated Regulation of Immune Responses in Cancer and Tumor Microenvironment. Front Immunol, 12: 774103. https:\/\/doi.org\/10.3389\/fimmu.2021.774103","DOI":"10.3389\/fimmu.2021.774103"},{"issue":"1","key":"5412_CR26","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","volume":"12","author":"Y Mou","year":"2019","unstructured":"Mou Y, Wang J, Wu J, He D, Zhang C, Duan C, Li B (2019) Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol 12(1):34. https:\/\/doi.org\/10.1186\/s13045-019-0720-y","journal-title":"J Hematol Oncol"},{"key":"5412_CR27","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.semcancer.2019.07.003","volume":"59","author":"AK Murugan","year":"2019","unstructured":"Murugan AK (2019) mTOR: role in cancer, metastasis and drug resistance. Semin Cancer Biol 59:92\u2013111. https:\/\/doi.org\/10.1016\/j.semcancer.2019.07.003","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"5412_CR28","doi-asserted-by":"publisher","first-page":"513","DOI":"10.4103\/jcrt.jcrt_528_18","volume":"16","author":"B Narayan","year":"2020","unstructured":"Narayan B, Urs AB, Augustine J, Singh H (2020) Role of phosphatase and tensin homolog in pathogenesis of ameloblastoma: an immunohistochemical study. J Cancer Res Ther 16(3):513\u2013516. https:\/\/doi.org\/10.4103\/jcrt.jcrt_528_18","journal-title":"J Cancer Res Ther"},{"key":"5412_CR29","doi-asserted-by":"crossref","unstructured":"Nav\u00e9 BT, Ouwens M, Withers DJ, Alessi DR, Shepherd PR (1999) Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem J, 344 (Pt 2):427\u2013431","DOI":"10.1042\/bj3440427"},{"issue":"9","key":"5412_CR30","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/modpathol.3800147","volume":"17","author":"L Nodit","year":"2004","unstructured":"Nodit L, Barnes L, Childers E, Finkelstein S, Swalsky P, Hunt J (2004) Allelic loss of tumor suppressor genes in ameloblastic tumors. Mod Pathol 17(9):1062\u20131067. https:\/\/doi.org\/10.1038\/modpathol.3800147","journal-title":"Mod Pathol"},{"issue":"10","key":"5412_CR31","doi-asserted-by":"publisher","first-page":"6065","DOI":"10.1038\/s41380-021-01251-6","volume":"26","author":"YN Ou","year":"2021","unstructured":"Ou YN, Yang YX, Deng YT, Zhang C, Hu H, Wu BS, Liu Y, Wang YJ, Zhu Y, Suckling J, Tan L, Yu JT (2021) Identification of novel drug targets for Alzheimer\u2019s disease by integrating genetics and proteomes from brain and blood. Mol Psychiatry 26(10):6065\u20136073. https:\/\/doi.org\/10.1038\/s41380-021-01251-6","journal-title":"Mol Psychiatry"},{"issue":"10","key":"5412_CR32","doi-asserted-by":"publisher","first-page":"7416","DOI":"10.1074\/jbc.275.10.7416","volume":"275","author":"RT Peterson","year":"2000","unstructured":"Peterson RT, Beal PA, Comb MJ, Schreiber SL (2000) FKBP12-rapamycin-associated protein (FRAP) autophosphorylates at serine 2481 under translationally repressive conditions. J Biol Chem 275(10):7416\u20137423. https:\/\/doi.org\/10.1074\/jbc.275.10.7416","journal-title":"J Biol Chem"},{"key":"5412_CR33","doi-asserted-by":"publisher","unstructured":"Popova NV, J\u00fccker M (2021) The Role of mTOR Signaling as a Therapeutic Target in Cancer. Int J Mol Sci 22(4): https:\/\/doi.org\/10.3390\/ijms22041743","DOI":"10.3390\/ijms22041743"},{"key":"5412_CR34","doi-asserted-by":"publisher","unstructured":"Qiao X, Shi J, Liu J, Liu J, Guo Y, Zhong M (2021) Recurrence rates of intraosseous ameloblastoma cases with conservative or aggressive treatment: a systematic review and meta-analysis. Front Oncol, 11: 647200. https:\/\/doi.org\/10.3389\/fonc.2021.647200","DOI":"10.3389\/fonc.2021.647200"},{"key":"5412_CR35","doi-asserted-by":"publisher","unstructured":"Qiu Y, Cao Y, Cao W, Jia Y, Lu N (2020) The application of ferroptosis in diseases. Pharmacol Res, 159: 104919. https:\/\/doi.org\/10.1016\/j.phrs.2020.104919","DOI":"10.1016\/j.phrs.2020.104919"},{"issue":"6","key":"5412_CR36","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1601-0825.2007.01421.x","volume":"14","author":"MA Scheper","year":"2008","unstructured":"Scheper MA, Chaisuparat R, Nikitakis NG, Sauk JJ (2008) Expression and alterations of the PTEN \/ AKT \/ mTOR pathway in ameloblastomas. Oral Dis 14(6):561\u2013568. https:\/\/doi.org\/10.1111\/j.1601-0825.2007.01421.x","journal-title":"Oral Dis"},{"issue":"10","key":"5412_CR37","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/j.1445-2197.2009.05061.x","volume":"79","author":"E Sham","year":"2009","unstructured":"Sham E, Leong J, Maher R, Schenberg M, Leung M, Mansour AK (2009) Mandibular ameloblastoma: clinical experience and literature review. ANZ J Surg 79(10):739\u2013744. https:\/\/doi.org\/10.1111\/j.1445-2197.2009.05061.x","journal-title":"ANZ J Surg"},{"key":"5412_CR38","doi-asserted-by":"publisher","unstructured":"Vered M, Wright JM (2022) Update from the 5th edition of the world health organization classification of head and neck tumors: odontogenic and maxillofacial bone tumours. Head Neck Pathol 16(1): 63\u201375. https:\/\/doi.org\/10.1007\/s12105-021-01404-7","DOI":"10.1007\/s12105-021-01404-7"},{"issue":"1","key":"5412_CR39","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1186\/s12885-022-09901-w","volume":"22","author":"C Wang","year":"2022","unstructured":"Wang C, Aikemu B, Shao Y, Zhang S, Yang G, Hong H, Huang L, Jia H, Yang X, Zheng M, Sun J, Li J (2022) Genomic signature of MTOR could be an immunogenicity marker in human colorectal cancer. BMC Cancer 22(1):818. https:\/\/doi.org\/10.1186\/s12885-022-09901-w","journal-title":"BMC Cancer"},{"key":"5412_CR40","doi-asserted-by":"publisher","unstructured":"Wang X, Liu K, Gong H, Li D, Chu W, Zhao D, Wang X, Xu D (2021) Death by histone deacetylase inhibitor quisinostat in tongue squamous cell carcinoma via apoptosis, pyroptosis, and ferroptosis. Toxicol Appl Pharmacol, 410: 115363. https:\/\/doi.org\/10.1016\/j.taap.2020.115363","DOI":"10.1016\/j.taap.2020.115363"},{"key":"5412_CR41","doi-asserted-by":"publisher","unstructured":"Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, Iynkkaran I, Liu Y, Maciejewski A, Gale N, Wilson A, Chin L, Cummings R, Le D, Pon A, Knox C, Wilson M (2018) DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res, 46(D1): D1074-d1082. https:\/\/doi.org\/10.1093\/nar\/gkx1037","DOI":"10.1093\/nar\/gkx1037"},{"key":"5412_CR42","doi-asserted-by":"publisher","unstructured":"Xiong G, Ouyang S, Xie N, Xie J, Wang W, Yi C, Zhang M, Xu X, Chen D, Wang C (2022) FOSL1 promotes tumor growth and invasion in ameloblastoma. Front Oncol 12: 900108. https:\/\/doi.org\/10.3389\/fonc.2022.900108","DOI":"10.3389\/fonc.2022.900108"},{"key":"5412_CR43","doi-asserted-by":"publisher","first-page":"1136777","DOI":"10.3389\/fcell.2023.1136777","volume":"11","author":"X Yang","year":"2023","unstructured":"Yang X, Lu Y, Zhou H, Jiang HT, Chu L (2023) Integrated proteome sequencing, bulk RNA sequencing and single-cell RNA sequencing to identify potential biomarkers in different grades of intervertebral disc degeneration. Front Cell Dev Biol 11:1136777. https:\/\/doi.org\/10.3389\/fcell.2023.1136777","journal-title":"Front Cell Dev Biol"},{"key":"5412_CR44","doi-asserted-by":"publisher","first-page":"1146617","DOI":"10.3389\/fonc.2023.1146617","volume":"13","author":"L Yu","year":"2023","unstructured":"Yu L, Luo Y, Ding X, Tang M, Gao H, Zhang R, Chen M, Liu Y, Chen Q, Ouyang Y, Wang X, Zhen H (2023) WIPI2 enhances the vulnerability of colorectal cancer cells to erastin via bioinformatics analysis and experimental verification. Front Oncol 13:1146617. https:\/\/doi.org\/10.3389\/fonc.2023.1146617","journal-title":"Front Oncol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-05412-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-023-05412-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-05412-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T10:10:03Z","timestamp":1699956603000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-023-05412-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,19]]},"references-count":44,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["5412"],"URL":"https:\/\/doi.org\/10.1007\/s00432-023-05412-8","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,19]]},"assertion":[{"value":"19 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that they have no confict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The studies involving human participants were reviewed and approved by the ethics committees of the Hospital of Stomatology of Hebei Medical University (Shijiazhuang, China) (No. [2020]005).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}